Research Agreement Extended for Nano-Proprietary

Nano-Proprietary, Inc.today announced that upon successful conclusion of its initial research project with a leading industrial chemical products company in Japan, its subsidiary, Applied Nanotech, Inc., has entered into an extension of its research and development partnership agreement to develop technical inks. Technical inks are inks that can be deposited using additive processes such as printing, in particular inkjet and screen printing. The target markets for technical inks are printed circuit boards, flexible electronics, photovoltaics, displays, communications instrumentation, and RFIDs.

The purpose of the partnership is to strategize and identify specific applications, and then develop technical inks to address each unique situation. The main area of research for the partnership has involved conductive inks using functionalized nanoparticles that will be manufactured and commercialized by the chemical company.

The extended project, located at ANI's facilities in Austin, Texas, will start October 1, 2007. ANI is providing a team of researchers, laboratory space, equipment and the necessary installations. During the next twelve months, ANI will receive a minimum of $625,000 in funding. Under this agreement, ANI's partner has the option of licensing the intellectual property developed under the R&D partnership.

"As a result of the first year research agreement, we identified specific metallic conductive inks to be utilized by the rapidly developing printed electronics industry," said Dr. Zvi Yaniv, President and CEO of ANI. "In the second year, we will improve the stability of our metallic inks and fine-tune alternative processing methods such as inkjet and laser deposition."

"I am very pleased with the progress that we have made to date on this project and this continuation is just one more example of our growing strength in the field of applied nanotechnology," said Tom Bijou, Chairman and Chief Executive Officer of Nano-Proprietary, Inc.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.